Investors & Media

Transformative science, targeted medicines

We are working to advanceĀ a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.

SEC Filings

SEC Filings

Filing date Form Description View
D View HTML
D View HTML
S-1

Registration statement for face-amount certificate companies

View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

View HTML
8-A12B

Registration of certain classes of securities 12(b) of the Securities Exchange Act

View HTML
CERTNAS

CERTNAS

View HTML
S-1MEF

Registration of up to an additional 20% of securities for any offering registered on an S-1

View HTML
3

Initial filing by director officer or owner of more than ten percent.

View HTML
3

Initial filing by director officer or owner of more than ten percent.

View HTML

Pagination